ArticleCancer2020

ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinib.

Yiting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.